论文信息 - Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease - 字舞流文

Intravenous treatment with human recombinant ApoA-I Milano reduces beta amyloid cerebral deposition in the APP23-transgenic mouse model of Alzheimer's disease

J. Montaner | M. Fatar | M. Hernández-Guillamon | S. Grudzenski | Paula Marazuela | Sofia Fernandez de Retana | Alex Montañola | Maialen De La Cuesta | Aina Batlle